(E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoic acid ethyl esterr
96%
- Product Code: 37235
Alias:
Pitavastatin 3-oxyethyl ester; (E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptyl Ethyl enoate; 3-oxopitavastatin ethyl ester; pitavastatin-3-oxyethyl ethyl ester; pitavastatin impurity 6
CAS:
148901-69-3
| Molecular Weight: | 447.50 g./mol | Molecular Formula: | C₂₇H₂₆FNO₄ |
|---|---|---|---|
| EC Number: | 604-664-8 | MDL Number: | MFCD11041029 |
| Melting Point: | Boiling Point: | 651.3℃ at 760 mmHg | |
| Density: | 1.268g/ml | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily investigated for its potential therapeutic applications, particularly in the field of medicinal chemistry. Its structure suggests activity as a modulator of specific biological pathways, likely targeting enzymes or receptors involved in inflammatory or metabolic processes. Researchers are exploring its efficacy in treating conditions such as chronic inflammation, autoimmune disorders, or metabolic diseases. Its ethyl ester group enhances bioavailability, making it a promising candidate for drug development. Preclinical studies focus on optimizing its pharmacokinetic properties and evaluating its safety and efficacy in animal models. If successful, it could lead to the development of novel pharmaceuticals with significant clinical benefits.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $35.88 |
+
-
|
| 1.000 | 10-20 days | $79.24 |
+
-
|
| 5.000 | 10-20 days | $273.59 |
+
-
|
| 10.000 | 10-20 days | $501.59 |
+
-
|
(E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoic acid ethyl esterr
This compound is primarily investigated for its potential therapeutic applications, particularly in the field of medicinal chemistry. Its structure suggests activity as a modulator of specific biological pathways, likely targeting enzymes or receptors involved in inflammatory or metabolic processes. Researchers are exploring its efficacy in treating conditions such as chronic inflammation, autoimmune disorders, or metabolic diseases. Its ethyl ester group enhances bioavailability, making it a promising candidate for drug development. Preclinical studies focus on optimizing its pharmacokinetic properties and evaluating its safety and efficacy in animal models. If successful, it could lead to the development of novel pharmaceuticals with significant clinical benefits.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :